| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/09/2006 | US7041796 C3b/C4b Complement Receptor-like molecules and uses thereof |
| 05/09/2006 | US7041795 Potassium channel interacting polypeptides and uses thereof |
| 05/09/2006 | US7041794 Nucleotide sequence comprises at least one new SNP (single nucleotide polymorphism) |
| 05/09/2006 | US7041792 Polypeptide free of botulinum toxin activity and free of toxoid which induces protective immunity to a type F botulinum toxin; vaccines; fusion protein with polypeptide for enhanced chromatographic purification |
| 05/09/2006 | US7041790 Fibrinogen binding moieties |
| 05/09/2006 | US7041788 Multimerized highly functional antifreeze protein |
| 05/09/2006 | US7041787 Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases |
| 05/09/2006 | US7041782 Lectin ss3939 DNA and polypeptides |
| 05/09/2006 | US7041678 Alkaloid that inhibits biosynthesis of mycotoxins and method for screening for mycotoxin inhibitors |
| 05/09/2006 | US7041654 Treating or preventing cancer by administering to subject a vector comprising a heterologous polynucleotide operably linked to one or more regulatory sequences derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence |
| 05/09/2006 | US7041653 Gene transcription and ionizing radiation: methods and compositions |
| 05/09/2006 | US7041648 Compositions and methods for treating female fertility |
| 05/09/2006 | US7041507 transfecting epidermal basal cells in vitro with a eukaryotic expression vector containing a cDNA encoding a human neurogenic transcription factor; growing with an antisense oligonucleotide comprising a segment of a human MSX1 gene and/or human HES1 gene; growing with a retinoid and a signal molecule |
| 05/09/2006 | US7041500 Insect cell line |
| 05/09/2006 | US7041498 Method for modulating processes mediated by farnesoid activated receptors |
| 05/09/2006 | US7041496 Nucleotide sequences coding polypeptide for use in the treatment of ataxia, alzheimer's, parkinson's, learning defects, nervous system, epilepsy and stroke disorders |
| 05/09/2006 | US7041495 nucleotide sequence encoding PNCK that is temporally expressed during postnatal mammary development in a spatially heterogeneous manner in certain subsets of cells, and overexpressed in a subset of primary breast cancers; used as prognostic tools, screening tools and in therapies |
| 05/09/2006 | US7041494 DNA encoding Slo2 and Slo4, potassium channel |
| 05/09/2006 | US7041491 NOD nucleic acids and polypeptides |
| 05/09/2006 | US7041490 Chlamydia trachomatis polynucleotides and vectors, recombinant host cells, DNA chips or kits containing the same |
| 05/09/2006 | US7041489 Vaccines |
| 05/09/2006 | US7041488 Endo-beta-1,4-glucanase from bacillus |
| 05/09/2006 | US7041487 Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 05/09/2006 | US7041486 Enzyme having decolorizing activity and method for decolorizing dyes by using the same |
| 05/09/2006 | US7041484 bound to A-type starch granules in wheat, barley, rye or triticale; not associated with B-type starch granules; starch biosynthesis |
| 05/09/2006 | US7041483 Expression modulating sequences |
| 05/09/2006 | US7041480 Amplification; polymerase chain reactions |
| 05/09/2006 | US7041478 Polypeptide for use in the treatment cancer, inflammation of autoimmune disorders |
| 05/09/2006 | US7041477 Production of heterologous proteins from Zygosaccharomyces bailii |
| 05/09/2006 | US7041476 Nucleotide sequences coding polypeptide for use tools in genetic engineering |
| 05/09/2006 | US7041475 Transport protein for use in human therapeutics and diagnostics |
| 05/09/2006 | US7041474 Nucleic acid encoding human tango 509 |
| 05/09/2006 | US7041473 Alzheimer's disease secretase, APP substrates therefor, and uses thereof |
| 05/09/2006 | US7041471 Carotene hydroxylase and method for producing xanthophyll derivatives |
| 05/09/2006 | US7041467 Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement |
| 05/09/2006 | US7041462 analyzing a non-denatured protein by high pressure liquid chromatography; by using chimeric genes replacing a native signal sequence with a different signal sequence resulting in the production of a conformer, one can compare the native protein with the product of the chimeric gene |
| 05/09/2006 | US7041461 Nucleotide sequences coding membrame protein for use in analgesics |
| 05/09/2006 | US7041460 Antibodies to monocyte-colony inhibitory factor (M-CIF) |
| 05/09/2006 | US7041453 Chimeric peptide nucleic acid for diagnosis, prevention and treatment of neurodegenerative, blood, muscular, cardiovascular, glandular and gastrointestinal disorders; rational drug design and screening |
| 05/09/2006 | US7041451 Electrochemiluminescence helicase assay |
| 05/09/2006 | US7041448 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of genetic disorders associated with brain, vision and gastrointestinal disorders |
| 05/09/2006 | US7041445 Long oligonucleotide arrays |
| 05/09/2006 | US7041443 For therapy of porcine subject at risk of infection by, or displaying symptoms of, a porcine reproductive and respiratory syndrome virus infection |
| 05/09/2006 | US7041442 peptides or derivatives of the 65 kD lower matrix phoshpoprotein of HCMV useful for determining whether subjects have been exposed to the virus and for determining the peptide-induced production of interferon- gamma and/or TNF- alpha in CD8+ T cells isolated from subjects |
| 05/09/2006 | US7041440 IP3-binding polypeptides and methods of using them |
| 05/09/2006 | US7041438 Conditioned medium collected from a culture of feeder cells with laminin or collagen |
| 05/09/2006 | US7041437 Genes and methods for the screening of therapeutics useful for treating impaired glucose tolerance conditions, as well as diagnostics and therapeutic compositions for identifying or treating such conditions. |
| 05/09/2006 | US7041300 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 05/09/2006 | US7041295 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 05/09/2006 | US7041291 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 05/09/2006 | US7041290 isolated monoclonal antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide of an epitope within or overlapping the amino acid sequence: SSDGLWNNNQTQLFLEHS; treating or preventing renal disease or injury |
| 05/09/2006 | US7041288 Antiinflammatory agents; antiallergens |
| 05/09/2006 | US7041284 Recombinant adenoviral vector and method of use |
| 05/09/2006 | US7041282 Ligands for flt3 receptors |
| 05/09/2006 | US7041276 Administering the agent to a teleost and detecting a response in the teleost indicating angiogenesis activity |
| 05/09/2006 | CA2175687C A bacterial nitroreductase gene-prodrug system |
| 05/09/2006 | CA2156857C Human b-lymphoblastoid cell line secreting anti-ganglioside antibody |
| 05/09/2006 | CA2093950C Subtilisin-like protease from aspergillus niger |
| 05/05/2006 | CA2523471A1 Expression cassettes for seed-preferential expression in plants |
| 05/04/2006 | WO2006047687A2 Compositions and methods for short interfering nucleic acid inhibition of nav1.8 |
| 05/04/2006 | WO2006047635A2 Methods and compositions for seprase inactivation |
| 05/04/2006 | WO2006047589A2 Improved alanine 2,3-aminomutases and related polynucleotides |
| 05/04/2006 | WO2006047536A2 Methods and kits for detecting mutations |
| 05/04/2006 | WO2006047469A2 Polypeptides having lipase activity and polynucleotides encoding same |
| 05/04/2006 | WO2006047412A2 Methods and kits for detecting germ cell genomic instability |
| 05/04/2006 | WO2006047394A1 Therapeutic rnai agents for treating psoriasis |
| 05/04/2006 | WO2006047390A2 Generation of plants with altered oil content |
| 05/04/2006 | WO2006047367A2 Suppression of endogenous immunoglubolin expression in non-human transgenic animals |
| 05/04/2006 | WO2006047358A1 Generation of plants with altered oil content |
| 05/04/2006 | WO2006047254A1 Assemblies of oligomeric amyloid beta protein and uses thereof |
| 05/04/2006 | WO2006047172A1 Tweak receptor |
| 05/04/2006 | WO2006047159A1 Generation of plants with altered oil content |
| 05/04/2006 | WO2006046994A2 Klf6 alternative splice forms and a germline klf6 dna polymorphism associated with increased cancer risk |
| 05/04/2006 | WO2006046951A2 Cell cycle arrest and apoptosis |
| 05/04/2006 | WO2006046861A2 Tomato plants having higher levels of resistance to botrytis |
| 05/04/2006 | WO2006046780A1 Method of stabilizing, and bluing, of anthocyanin pigment using gene coding for transferase of aromatic acyl to 3’-position of anthocyanin |
| 05/04/2006 | WO2006046751A1 Anti-glypican 3 antibody having modified sugar chain |
| 05/04/2006 | WO2006046739A1 Remedy for inflammatory diseases |
| 05/04/2006 | WO2006046694A1 Method of gene screening with yeast having ergosterol synthase undergoing inducible expression |
| 05/04/2006 | WO2006046693A1 Method of assyaing htlv-i-specific t cell response |
| 05/04/2006 | WO2006046661A1 Interleukin-6 inhibitor |
| 05/04/2006 | WO2006046613A1 Il-18-like peptide, fused peptide thereof, method of producing the same and use of the same |
| 05/04/2006 | WO2006046569A1 Neuronal differentiation promoting peptide |
| 05/04/2006 | WO2006046505A1 Identification marker responsive to interferon therapy for renal cell cancer |
| 05/04/2006 | WO2006046504A1 Method of acquiring signal-dependent nuclear transport protein gene |
| 05/04/2006 | WO2006046455A1 Novel carbonyl reductase, gene therefor and use thereof |
| 05/04/2006 | WO2006046352A1 Novel auxotrophic fission yeast |
| 05/04/2006 | WO2006046243A1 Sv40 for gene therapy of renal disorders |
| 05/04/2006 | WO2006046148A2 Rna constructs |
| 05/04/2006 | WO2006046076A2 Applications of isolated nucleic acid fragments comprising cpg islands |
| 05/04/2006 | WO2006046073A2 C1q related protein |
| 05/04/2006 | WO2006045891A1 Avidin-like proteins from symbiotic bacteria |
| 05/04/2006 | WO2006045829A1 Plants having improved growth characteristics and method for making the same |
| 05/04/2006 | WO2006045633A1 Stress tolerant cotton plants |
| 05/04/2006 | WO2006045631A2 Plasmids for gene transfer by bacterial conjugation |
| 05/04/2006 | WO2006045591A2 Method and constructs for delivering double stranded rna to pest organisms |
| 05/04/2006 | WO2006045590A2 Multidomain rna molecules comprising at least one aptamer for delivering double stranded rna to pest organisms |
| 05/04/2006 | WO2006045476A2 Gpr17 modulators, method of screening and uses thereof |
| 05/04/2006 | WO2006035442A3 Collagen producing plants and methods of generating and using same |
| 05/04/2006 | WO2006033014A3 Modulation of flowering time and growth cessation in perennial plants |